BR9510462A - Micropartículas reticuladas e seu uso como veículos terapéuticos - Google Patents

Micropartículas reticuladas e seu uso como veículos terapéuticos

Info

Publication number
BR9510462A
BR9510462A BR9510462A BR9510462A BR9510462A BR 9510462 A BR9510462 A BR 9510462A BR 9510462 A BR9510462 A BR 9510462A BR 9510462 A BR9510462 A BR 9510462A BR 9510462 A BR9510462 A BR 9510462A
Authority
BR
Brazil
Prior art keywords
cross
microparticles
vehicles
linked
linked microparticles
Prior art date
Application number
BR9510462A
Other languages
English (en)
Inventor
Andrew Derek Sutton
Richard Alan Johnson
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andaris Ltd filed Critical Andaris Ltd
Publication of BR9510462A publication Critical patent/BR9510462A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9510462A 1994-12-16 1995-12-14 Micropartículas reticuladas e seu uso como veículos terapéuticos BR9510462A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94309417 1994-12-16
PCT/GB1995/002925 WO1996018388A2 (en) 1994-12-16 1995-12-14 Cross-linked microparticles and their use as therapeutic vehicles

Publications (1)

Publication Number Publication Date
BR9510462A true BR9510462A (pt) 1998-12-15

Family

ID=8217949

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9510462A BR9510462A (pt) 1994-12-16 1995-12-14 Micropartículas reticuladas e seu uso como veículos terapéuticos

Country Status (19)

Country Link
EP (1) EP0796090B1 (pt)
JP (1) JP4350165B2 (pt)
CN (1) CN1175208A (pt)
AT (1) ATE234080T1 (pt)
AU (1) AU692019B2 (pt)
BR (1) BR9510462A (pt)
CA (1) CA2207077C (pt)
CZ (1) CZ183797A3 (pt)
DE (1) DE69529917T2 (pt)
DK (1) DK0796090T3 (pt)
ES (1) ES2191721T3 (pt)
FI (1) FI972546A (pt)
HU (1) HUT77369A (pt)
NO (1) NO972554L (pt)
NZ (1) NZ297072A (pt)
PL (1) PL321018A1 (pt)
PT (1) PT796090E (pt)
WO (1) WO1996018388A2 (pt)
ZA (1) ZA9510702B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391343B1 (en) 1991-01-15 2002-05-21 Hemosphere, Inc. Fibrinogen-coated particles for therapeutic use
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5955108A (en) * 1994-12-16 1999-09-21 Quadrant Healthcare (Uk) Limited Cross-linked microparticles and their use as therapeutic vehicles
JP4024302B2 (ja) * 1996-05-17 2007-12-19 クアドラント、 ドラッグ、 デリバリー、 リミテッド 微粒子および創傷治療におけるその用途
GB9610830D0 (en) 1996-05-23 1996-07-31 Andaris Ltd Use of hollow microcapsules
GB9615435D0 (en) * 1996-07-23 1996-09-04 Andaris Ltd Spray-dried product and its therapeutic use
GB9621825D0 (en) * 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
EP0949932A1 (en) * 1996-10-19 1999-10-20 Quadrant Healthcare (UK) Limited Use of hollow microcapsules in diagnosis and therapy
JP2001504813A (ja) * 1996-10-21 2001-04-10 クウォドラント、ヘルスケアー、（ユーケー）、リミテッド 代用血小板、及びそれらの製造に適した抱合法
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
AU5871898A (en) * 1997-01-30 1998-08-25 Andaris Limited Microparticles and their use in cancer treatment
US6264988B1 (en) 1997-06-05 2001-07-24 Hemosphere, Inc. Fibrinogen-coated microspheres
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9724143D0 (en) * 1997-11-14 1998-01-14 Andaris Ltd Pharmaceutical conjugate
GB9825105D0 (en) * 1998-11-16 1999-01-13 Andaris Ltd Pharamaceutical conjugates
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0323378D0 (en) * 2003-10-07 2003-11-05 Univ Leicester Therapeutic agent
EP2497785B1 (en) * 2004-01-07 2018-09-12 Seikagaku Corporation Hyaluronic acid derivative and drug containing the same
GB0623607D0 (en) 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US7914999B2 (en) * 2006-12-29 2011-03-29 Abbott Laboratories Non-denaturing lysis reagent
GB0814302D0 (en) 2008-08-05 2008-10-01 Coretherapix Slu Compounds and methods
EP2216054A1 (en) 2009-02-06 2010-08-11 ProFibrix BV Biodegradable extravascular support
GB0909131D0 (en) 2009-05-28 2009-07-01 Quadrant Drug Delivery Ltd Dry powder fibrin sealant
GB0909136D0 (en) 2009-05-28 2009-07-01 Profibrix Bv Dry powder composition
AU2011204558B2 (en) 2010-01-08 2015-01-22 Mallinckrodt Pharma Ip Trading D.A.C. Dry powder fibrin sealant
NO20110653A1 (no) 2011-05-02 2012-11-05 Spiro Medical As Respirasjonsovervakning
RU2013155713A (ru) 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0494417B1 (en) * 1991-01-10 1996-04-17 Basf Corporation Process for crosslinking gelatin and for incorporation a material therein
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents

Also Published As

Publication number Publication date
CA2207077C (en) 2007-02-06
PL321018A1 (en) 1997-11-24
FI972546A0 (fi) 1997-06-16
WO1996018388A2 (en) 1996-06-20
DE69529917D1 (de) 2003-04-17
FI972546A (fi) 1997-07-04
JP4350165B2 (ja) 2009-10-21
EP0796090A2 (en) 1997-09-24
CZ183797A3 (en) 1997-11-12
NZ297072A (en) 1999-03-29
HUT77369A (hu) 1998-03-30
EP0796090B1 (en) 2003-03-12
PT796090E (pt) 2003-07-31
MX9704503A (es) 1997-10-31
AU692019B2 (en) 1998-05-28
NO972554D0 (no) 1997-06-05
AU4184996A (en) 1996-07-03
ZA9510702B (en) 1996-12-17
NO972554L (no) 1997-06-05
JPH10510527A (ja) 1998-10-13
ATE234080T1 (de) 2003-03-15
ES2191721T3 (es) 2003-09-16
WO1996018388A3 (en) 1996-08-29
DK0796090T3 (da) 2003-06-23
CN1175208A (zh) 1998-03-04
DE69529917T2 (de) 2003-12-11
CA2207077A1 (en) 1996-06-20

Similar Documents

Publication Publication Date Title
BR9510462A (pt) Micropartículas reticuladas e seu uso como veículos terapéuticos
ATE204487T1 (de) Behandlung von untereinander vernetzten partikelaggregaten mit latex zur erhöhung der flexibilität von porösen absorbierenden makrostrukturen
MX9605993A (es) Prenda desechable absorbedora de fluidos del cuerpo.
MX9702357A (es) Microparticulas secadas por aspersion como vehiculos terapeuticos.
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
WO1995000184B1 (en) Dried hydrogel from hydrophylic-hygroscopic polymer
JPH0552221B2 (pt)
ES2084825T3 (es) Procedimiento de preparacion de poliamidas entrecruzadas.
DE69725331D1 (de) Absorbierendes quellbares material aus vernetztem polyaspartat
PT1010688E (pt) 2-fenil-1-(3,4-di-hidroxi-5-nitrofenil)-1-etanonas substituidas seu uso no tratamento de algumas perturbacoes do sistema nervoso central e periferico e formulacoes do sistema nervoso central e periferico e formulacoes farmaceuticas que as contem
MY110150A (en) Highly absorbent polymer
Philpott et al. Improved selective cytotoxicity with an antibody-diphtheria toxin conjugate
ATE254481T1 (de) Radioaktiven chitosankomplex und deren anwendung in strahlungstherapie
DE68917429D1 (de) Kationische Präparate zur topischen Anwendung.
SE8601563D0 (sv) Matrismaterial, forfarande for framstellning derav och anvendning derav
Paul et al. Modified hydroxyapatite microspheres as immunoadsorbent for plasma perfusion: preliminary study
Baciu Nervolus Control of the Phagocytic System
Lou et al. In-vivo and in-vitro targeting of a murine sarcoma by gelatin microparticles loaded with a glycan (PS1)
WO1997035884A8 (en) Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies
RU95105648A (ru) Средство для лечения ран
SU1369055A1 (ru) Биоспецифические адсорбенты липопротеидов и холестерина
RU97111885A (ru) Сшитые микрочастицы и их применение в качестве терапевтических носителей
MY100419A (en) Sanitary article
RU97102742A (ru) Способ иммобилизации бифидобактерий на биогенном носителе

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law